Genetic polymorphisms in ADH1B and/or ALDH2 can result in different enzymatic activities that have a major impact on the risk of ESCC as well as head and neck squamous cell carcinoma (HNSCC) [13,14,15,16]. This evidence concerns the gene ADH1B and head and neck squamous cell carcinoma.